Yu Lu

机构：Guizhou Provincial People's Hospital, Taizhou University · ORCID：0000-0003-4151-3120

发表论文 101 篇 · 总被引 3007 次 · h-index 27

代表论文

• Region‐Specific CD16 + Neutrophils Promote Colorectal Cancer Progression by Inhibiting Natural Killer Cells (2024 · Advanced Science · 被引 30)
• PAD4 Inhibitor‐Functionalized Layered Double Hydroxide Nanosheets for Synergistic Sonodynamic Therapy/Immunotherapy Of Tumor Metastasis (2024 · Advanced Science · 被引 30)
• Irisin preserves mitochondrial integrity and function in tubular epithelial cells after ischemia–reperfusion‐induced acute kidney injury (2024 · Acta Physiologica · 被引 20)
• A β-Carboline Derivate PAD4 Inhibitor Reshapes Neutrophil Phenotype and Improves the Tumor Immune Microenvironment against Triple-Negative Breast Cancer (2024 · Journal of Medicinal Chemistry · 被引 20)
• pH‐Responsive, Self‐Assembled Ruthenium Nanodrug: Dual Impact on Lysosomes and DNA for Synergistic Chemotherapy and Immunogenic Cell Death (2024 · Small · 被引 17)
• Oral ruthenium-based PAD4 inhibitor modulates immunogenic cell death and neutrophil extracellular traps in triple-negative breast cancer (2025 · Journal of Controlled Release · 被引 10)